Furthermore, the glucose profile was unchanged after adding-on PCSK9-i therapy; moreover, at baseline, 3 FH patients were diabetics and new cases of T2D was not detected after adding-on PCSK9-i therapy. Here, PCSK9 is linked to type 2 diabetes mellitus.